Induction of diabetes and oral glucose tolerance tests during and after chronic beta-blockade.
D000368:Aged; D000526:Alprenolol / Q000009:adverse effects* / Q000627:therapeutic use; D001786:Blood Glucose; D002784:Cholesterol / Q000097:blood; D002986:Clinical Trials as Topic; D048909:Diabetes Complications; D003920:Diabetes Mellitus / Q000139:chemically induced*; D005260:Female; D005951:Glucose Tolerance Test; D006801:Humans; D007328:Insulin / Q000097:blood; D008297:Male; D008875:Middle Aged; D009203:Myocardial Infarction / Q000097:blood / Q000150:complications / Q000188:drug therapy; D010919:Placebos; D011188:Potassium / Q000097:blood; D013268:Stimulation, Chemical; D013997:Time Factors
D001786:Blood Glucose; D007328:Insulin; D010919:Placebos; D000526:Alprenolol; D002784:Cholesterol; D011188:Potassium